Beijing - CoronaVac, an inactivated vaccine against Covid-19, which was developed by the pharmaceutical company Sinovac, has proved to be safe and effective to reinforce the immune system during clinical trials on humans, Chinese media reported on Tuesday.
According to China Daily, more than 90% of volunteers administered with the coronavirus shot on a 14-day interval have induced neutralizing antibodies two weeks after inoculation, leaving no serious side effects other than mild pain in the area where the vaccine was administered, fatigue and low fever in some of them.
The trials involved 743 healthy individuals aged 18 to 59, and were carried out using the random, double blind and controlled placebo methods.
Sinovac plans to share the results with the international community soon in articles, and will proceed to carry out the third phase of trials in Brazil, although it said that conclusions will take several months.
However, the company assured that CoronaVac will be available to people if it shows positive results.
Havana - Havana Historian Eusebio Leal Spengler, one of Cuba's most renowned intellectuals, died on Friday of a painful illness at the age of 77.
Leal's work was transcendental to the preservation of the legacy of illustrious figures who are paradigms in Cuba and Ibero-America.Read More
Havana - The film Mambo Man, by Cuban musician Edesio Alejandro and British-Iranian film-maker Mo Fini, received today a new award after being chosen as the Best Feature Film of the season at Best Global Shorts festival.Read More
A Greek initiative to award the Nobel Peace Prize to the Cuban doctors who are fighting against the Covid-19 in the world was presented in this capital.Read More